<--- Back to Details
First PageDocument Content
Bristol-Myers Squibb / Pharmacology / Fixed dose combination / Organofluorides / Non-nucleoside reverse transcriptase inhibitors / Emtricitabine/tenofovir/efavirenz / Tenofovir / Efavirenz / Emtricitabine / Gilead Sciences / Chemistry / Organic chemistry
Date: 2013-04-19 14:05:26
Bristol-Myers Squibb
Pharmacology
Fixed dose combination
Organofluorides
Non-nucleoside reverse transcriptase inhibitors
Emtricitabine/tenofovir/efavirenz
Tenofovir
Efavirenz
Emtricitabine
Gilead Sciences
Chemistry
Organic chemistry

HIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 1,16 MB

Share Document on Facebook

Similar Documents

Chemistry_BS_Biochemistry.pdf

Chemistry_BS_Biochemistry.pdf

DocID: 1xUCR - View Document

Chemistry_BS_Environmental Chemistry.pdf

Chemistry_BS_Environmental Chemistry.pdf

DocID: 1xUxX - View Document

Chemistry, BA

Chemistry, BA "DBEFNJD.BQ  General

DocID: 1xU5A - View Document

The Next Bigly Thing -- Torsion Chemistry 80% Faster Reactions, 50% Less Energy with

The Next Bigly Thing -- Torsion Chemistry 80% Faster Reactions, 50% Less Energy with "Activators" by Robert A. Nelson Science has bestowed many wonderments upon us, but the Return-On-Investment is quickly diminishing (th

DocID: 1xTUH - View Document

Chemistry_BS_General BS to MS Accelerated Pathway.pdf

Chemistry_BS_General BS to MS Accelerated Pathway.pdf

DocID: 1xTpY - View Document